Form 4: Centessa Pharmaceuticals Chief Business Officer Sells Shares to Cover Tax Obligations

Centessa Pharmaceuticals' Chief Business Officer, Gregory M. Weinhoff, sold 11,742 ordinary shares to cover tax obligations related to vesting restricted share units.

Summary

• Gregory M. Weinhoff, the Chief Business Officer of Centessa Pharmaceuticals, sold 11,742 ordinary shares on December 31, 2024.
• The sale was executed at a price of $16.35 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of restricted share units.
• Following the transaction, Mr. Weinhoff directly owns 171,524 ordinary shares.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of any positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive share sales to cover tax obligations are a common practice across the pharmaceutical industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar tax-related sales by executives.
• This transaction is consistent with standard practices for executives managing their equity compensation.

Stakeholder Impact

• The share sale has a minimal impact on shareholders as it is a routine transaction for tax purposes.

Key Dates

Keywords

Centessa Pharmaceuticals, Gregory M. Weinhoff, share sale, insider trading, tax obligations, restricted share units, CNTA